April 17, 2013
DePuy Synthes Spine parent company Johnson & Johnson reported the acquisition of Synthes and subsequent divestiture of the DePuy trauma business contributed to a 5.7 percent worldwide operational sales growth in the first quarter of 2013.
February 05, 2013
The New Jersey Health Foundation received a $2 million endowment in honor of the late orthopedist Fred Behrens, MD.
January 18, 2013
Medical device manufacturer Synthes USA has filed a civil action claim against a former employee, saying the man violated his contract, according to The Pennsylvania Record.
A German District Court in Mannheim has dismissed Synthes' patent infringement claims against Spinal Kinetics, and the court ordered Synthes to pay certain litigation costs.
April 19, 2012
The European Commission has approved Johnson & Johnson's $21.3 billion acquisition of Synthes.
April 09, 2012
Emerge Medical CEO John Marotta, who previously served as a sales representative for Synthes, recently filed a counterclaim against Synthes alleging antitrust violations, according to a Mass Device report.
March 20, 2012
Synthes announced it signed a license and development agreement with Kuros to commercialize Kuros' synthetic matrix technology.
Johnson & Johnson recently made concessions to convince the European Union's antitrust regulator that it's acquisition of Swiss company Synthes is clear of any issues, according to a New York Times report.
February 17, 2012
Synthes reported full year earnings at $966.8 million, a 6.5 percent increase over 2010, according to a company news release.
January 03, 2012
Synthes, a Swiss spine device company currently in the middle of being acquired by Johnson & Johnson, recently filed suit against three former sales representatives and Stryker for breaching company loyalty, according to a Philadelphia Inquirer news report.